Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

Gillian I. Rice; Candice Meyzer; Naïm Bouazza; Marie Hully; Nathalie Boddaert; Michaela Semeraro; Leo A.H. Zeef; Flore Rozenberg; Vincent Bondet; Darragh Duffy; Alba Llibre; Jinmi Baek; Mame N. Sambe; Elodie Henry; Valerie Jolaine; Christine Barnerias; Magalie Barth; Alexandre Belot; Claude Cances; François-Guillaume Debray; Diane Doummar; Marie-Louise Frémond; Naoki Kitabayashi; Alice Lepelley; Virginie Levrat; Isabelle Melki; Pierre Meyer; Marie-Christine Nougues; Florence Renaldo; Mathieu P. Rodero; Diana Rodriguez; Agathe Roubertie; Luis Seabra; Carolina Uggenti; Hendy Abdoul; Jean-Marc Treluyer; Isabelle Desguerre; Stéphane Blanche; Yanick J. Crow

Journal ArticleOPEN ACCESS

Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

Rice G
Meyzer C
Bouazza N
et al.

New England Journal of Medicine (2018) 379(23) 2275-2277

DOI: 10.1056/nejmc1810983

106Citations

80Readers

Abstract

ART for the Aicardi–Goutières Syndrome The genetic encephalopathy Aicardi–Goutières syndrome is thought to be due to misidentification of self-derived nucleic acids and the induction of a type I in...

Cite

CITATION STYLE

APA

Rice, G. I., Meyzer, C., Bouazza, N., Hully, M., Boddaert, N., Semeraro, M., … Crow, Y. J. (2018). Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome. New England Journal of Medicine, 379(23), 2275–2277. https://doi.org/10.1056/nejmc1810983

Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome

Abstract

Cite

Register to see more suggestions